Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254527 · ClinicalTrials.gov registry record
Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 477
- Enrollment target
NCT00254527: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT00254527 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 477 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00254527 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 477 participants
- Enrollment target
Study Summary
The intent of this study is to: 1. Define the prevalence of MRSA carriage in the pediatric population in Kansas City. 2. Systematically define patient risk factors for MRSA carriage and infection. 3. Characterize the unique genetic characteristics of MRSA strains, both community acquired (CA) and healthcare associated (HCA) that are present in the different pediatric populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-04 |
What the finished NCT00254527 record still lists
NCT00254527 is an observational study that tracks outcomes without assigning an intervention. The registered 477 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00254527 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00254527 about?
NCT00254527 is a clinical study titled "Colonization, Infection, and Molecular Typing of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Children.". The intent of this study is to: 1. Define the prevalence of MRSA carriage in the pediatric population in Kansas City. 2. Systematically define patient risk factors for MRSA carriage and infection. 3. Characterize the unique genetic characteristics of MRSA strains, both community acquired (CA) and h...
What is the current status of trial NCT00254527?
This trial is currently completed. The enrollment target is 477 participants. The study started on 2005-01. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00254527?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
- NCT06997497 · 477 participants · Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- NCT05446272 · 478 participants · NA
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
- NCT06172296 · 478 participants · Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia